Clinical Trial: CleaRRAflow: Isotonic Solution vs. TPA for IVH Clearance

U.S., June 12 -- ClinicalTrials.gov registry received information related to the study (NCT07643493) titled 'CleaRRAflow: Isotonic Solution vs. TPA for IVH Clearance' on May 12.

Brief Summary: The study aims to investigate the effect of continuous tPA irrigation into the ventricles. Investigators believe it may be superior to the traditional every 8-hour bolus dosing and continuous isotonic solution irrigation alone. The protocol plans to analyze blood clearance and functional outcomes in the patients.

Study Start Date: June 01

Study Type: INTERVENTIONAL

Condition: Tissue Plasminogen Activator Intraventricular Brain Hemorrhage

Intervention: DRUG: Tissue Plasminogen Activator (tPA)

Tissue Plasminogen Activator (tPA) is infused throug...